Tonix Pharmaceuticals Holding Corp Share Price Nasdaq
Stocks
US8902604094
Pharmaceuticals
| Market Cap | 161M 140M 130M 120M 225M 15.36B 229M 1.54B 601M 7.63B 604M 591M 25.65B | P/E 2026 * |
-1x | P/E 2027 * | -1.6x |
|---|---|---|---|---|---|
| Enterprise Value | 161M 140M 130M 120M 225M 15.36B 229M 1.54B 601M 7.63B 604M 591M 25.65B | EV / Sales 2026 * |
4.71x | EV / Sales 2027 * | 2.04x |
| Free-Float |
99.86% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tonix Pharmaceuticals Holding Corp
| 1 day | +83.42% |
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 15/11/2007 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 31/01/2016 |
Siobhan Fogarty
CTO | Chief Tech/Sci/R&D Officer | 57 | 03/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CHM | Chairman | 68 | 30/09/2011 |
Margaret Bell
BRD | Director/Board Member | 66 | 11/09/2017 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 04/09/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.42% | -17.57% | - | - | 161M | |
| -4.55% | -2.61% | +51.95% | +151.91% | 1,030B | |
| -3.66% | -1.33% | +52.95% | +46.62% | 617B | |
| -2.24% | +0.19% | +35.97% | +70.64% | 455B | |
| +0.79% | +0.23% | +38.43% | +31.52% | 350B | |
| +0.32% | +0.16% | +34.94% | +39.56% | 299B | |
| -0.08% | +0.47% | +12.42% | +13.80% | 265B | |
| -9.07% | -6.47% | -4.66% | -45.09% | 225B | |
| 0.00% | +4.34% | +28.63% | +64.00% | 209B | |
| -1.09% | +0.32% | +14.40% | +70.80% | 163B | |
| Average | +7.38% | +4.83% | +29.45% | +49.31% | 401.41B | |
| Weighted average by Cap. | -0.66% | +4.87% | +37.91% | +71.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34.18M 29.69M 27.57M 25.43M 47.9M 3.26B 48.77M 326M 128M 1.62B 128M 126M 5.45B | 78.93M 68.56M 63.67M 58.72M 111M 7.54B 113M 754M 295M 3.74B 296M 290M 12.59B |
| Net income | -170M -148M -137M -126M -238M -16.23B -242M -1.62B -635M -8.06B -638M -624M -27.1B | -152M -132M -122M -113M -213M -14.5B -217M -1.45B -568M -7.2B -570M -558M -24.21B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
